Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
13.07
+0.17 (1.32%)
At close: Dec 20, 2024, 4:00 PM
13.10
+0.03 (0.23%)
After-hours: Dec 20, 2024, 7:53 PM EST
Capricor Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 68.38 | 14.69 | 9.6 | 34.89 | 32.67 | 3.9 | Upgrade
|
| Short-Term Investments | 16.65 | 24.79 | 31.82 | - | - | 5.99 | Upgrade
|
| Cash & Short-Term Investments | 85.03 | 39.49 | 41.42 | 34.89 | 32.67 | 9.89 | Upgrade
|
| Cash Growth | 198.12% | -4.67% | 18.74% | 6.79% | 230.45% | 36.23% | Upgrade
|
| Receivables | 0.41 | 10.37 | 0.55 | 0.39 | 0.06 | 0.15 | Upgrade
|
| Prepaid Expenses | 0.39 | 1 | 0.92 | 1.16 | 0.96 | 0.51 | Upgrade
|
| Total Current Assets | 85.82 | 50.86 | 42.89 | 36.44 | 33.68 | 10.54 | Upgrade
|
| Property, Plant & Equipment | 6.81 | 7.61 | 6.94 | 4.62 | 0.85 | 0.44 | Upgrade
|
| Other Intangible Assets | - | - | - | - | 0 | 0.01 | Upgrade
|
| Other Long-Term Assets | 0.32 | 0.27 | 0.27 | 0.28 | 0.09 | 0.12 | Upgrade
|
| Total Assets | 92.95 | 58.73 | 50.09 | 41.33 | 34.62 | 11.11 | Upgrade
|
| Accounts Payable | 6.52 | 6.22 | 4.83 | 3.12 | 2.72 | 0.89 | Upgrade
|
| Accrued Expenses | 0.01 | 0.03 | 0.09 | 0.6 | 0.01 | 0.01 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0.25 | - | Upgrade
|
| Current Portion of Leases | 0.81 | 0.75 | 0.68 | 0.42 | - | - | Upgrade
|
| Current Unearned Revenue | 13.13 | 24.27 | 17.98 | - | - | - | Upgrade
|
| Total Current Liabilities | 20.48 | 31.27 | 23.59 | 4.13 | 2.97 | 0.9 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.07 | - | Upgrade
|
| Long-Term Leases | 0.83 | 1.49 | 1.88 | 2.45 | - | - | Upgrade
|
| Long-Term Unearned Revenue | - | - | 9.47 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 3.38 | 3.38 | 3.38 | 3.38 | 3.38 | 3.38 | Upgrade
|
| Total Liabilities | 24.69 | 36.13 | 38.31 | 9.96 | 6.42 | 4.27 | Upgrade
|
| Common Stock | 0.04 | 0.03 | 0.03 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 260.85 | 181.7 | 148.74 | 139.4 | 116.22 | 81.22 | Upgrade
|
| Retained Earnings | -192.72 | -159.37 | -137.08 | -108.06 | -88.04 | -74.38 | Upgrade
|
| Comprehensive Income & Other | 0.1 | 0.24 | 0.11 | - | - | -0 | Upgrade
|
| Shareholders' Equity | 68.26 | 22.6 | 11.79 | 31.37 | 28.2 | 6.84 | Upgrade
|
| Total Liabilities & Equity | 92.95 | 58.73 | 50.09 | 41.33 | 34.62 | 11.11 | Upgrade
|
| Total Debt | 1.65 | 2.24 | 2.56 | 2.87 | 0.32 | - | Upgrade
|
| Net Cash (Debt) | 83.38 | 37.25 | 38.86 | 32.01 | 32.35 | 9.89 | Upgrade
|
| Net Cash Growth | 219.36% | -4.14% | 21.38% | -1.03% | 227.23% | 36.23% | Upgrade
|
| Net Cash Per Share | 2.63 | 1.39 | 1.58 | 1.39 | 2.08 | 2.66 | Upgrade
|
| Filing Date Shares Outstanding | 45.47 | 31.4 | 25.26 | 24.3 | 22.8 | 8.91 | Upgrade
|
| Total Common Shares Outstanding | 40.33 | 31.15 | 25.24 | 24.19 | 20.58 | 5.23 | Upgrade
|
| Working Capital | 65.35 | 19.59 | 19.3 | 32.3 | 30.71 | 9.65 | Upgrade
|
| Book Value Per Share | 1.69 | 0.73 | 0.47 | 1.30 | 1.37 | 1.31 | Upgrade
|
| Tangible Book Value | 68.26 | 22.6 | 11.79 | 31.37 | 28.2 | 6.83 | Upgrade
|
| Tangible Book Value Per Share | 1.69 | 0.73 | 0.47 | 1.30 | 1.37 | 1.31 | Upgrade
|
| Machinery | 6.3 | 5.64 | 4.38 | 0.04 | 1.52 | 0.97 | Upgrade
|
| Leasehold Improvements | 2.26 | 2.13 | 1.39 | 2.51 | 0.05 | 0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.